Literature DB >> 8425455

Can cyclosporin prevent proctocolectomy in severe steroid-refractory ulcerative colitis? Lessons from a case report.

H Allgayer, K H Seitz, R Gugler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8425455     DOI： 10.1007/bf01307563

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  Cortisone and corticotrophin in ulcerative colitis.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1959-02-14

2.  Cyclosporin treatment for severe active ulcerative colitis.

Authors:  G Bianchi Porro; M Petrillo; S Ardizzone
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

3.  A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

Authors:  J Brynskov; L Freund; S N Rasmussen; K Lauritsen; O S de Muckadell; N Williams; A S MacDonald; R Tanton; F Molina; M C Campanini
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

4.  Cyclosporin in ulcerative colitis.

Authors:  S Gupta; A Keshavarzian; H J Hodgson
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

5.  Cyclosporin for the treatment of severe inflammatory bowel disease.

Authors:  K Baker; D P Jewell
Journal:  Aliment Pharmacol Ther       Date:  1989-04       Impact factor: 8.171

6.  Cyclosporin A treatment in inflammatory bowel disease.

Authors:  E F Stange; W E Fleig; E Rehklau; H Ditschuneit
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

7.  Preliminary report: cyclosporin in treatment of severe active ulcerative colitis.

Authors:  S Lichtiger; D H Present
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

8.  Intensive intravenous treatment of ulcerative colitis.

Authors:  G Järnerot; P Rolny; H Sandberg-Gertzén
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682
  8 in total
  1 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.